Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans

被引:210
作者
Pym, AS
Saint-Joanis, B
Cole, ST
机构
[1] Inst Pasteur, Unite Genet Mol Bacterienne, F-75724 Paris, France
[2] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
关键词
D O I
10.1128/IAI.70.9.4955-4960.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The usefulness of isoniazid (INH),. a key component of short-course chemotherapy of tuberculosis, is threatened by the emergence of drug-resistant strains of Mycobacterium tuberculosis with mutations in the katG gene. It is shown here that the most commonly occurring KatG mutation, where Ser 315 is replaced by Thr (S315T), is associated with clinically significant levels of INH resistance. In contrast to another resistant isolate, in which Pro replaces Thr 275, the S315T mutant produces active catalase-peroxidase and is virulent in the mouse model of the disease, indicating that a significant loss of bacterial fitness does not result from this frequent mutation. The implications of this finding for the transmission and reactivation of multidrug-resistant strains of M. tuberculosis are severe.
引用
收藏
页码:4955 / 4960
页数:6
相关论文
共 43 条
[1]   Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice [J].
Adams, LB ;
Dinauer, MC ;
Morgenstern, DE ;
Krahenbuhl, JL .
TUBERCLE AND LUNG DISEASE, 1997, 78 (5-6) :237-246
[2]   The biological cost of antibiotic resistance [J].
Andersson, DI ;
Levin, BR .
CURRENT OPINION IN MICROBIOLOGY, 1999, 2 (05) :489-493
[3]   Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis [J].
Billington, OJ ;
McHugh, TD ;
Gillespie, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1866-1869
[4]   Fitness of antibiotic-resistant microorganisms and compensatory mutations [J].
Böttger, EC ;
Springer, B ;
Pletschette, M ;
Sander, P .
NATURE MEDICINE, 1998, 4 (12) :1343-1344
[5]   Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J].
Cole, ST ;
Brosch, R ;
Parkhill, J ;
Garnier, T ;
Churcher, C ;
Harris, D ;
Gordon, SV ;
Eiglmeier, K ;
Gas, S ;
Barry, CE ;
Tekaia, F ;
Badcock, K ;
Basham, D ;
Brown, D ;
Chillingworth, T ;
Connor, R ;
Davies, R ;
Devlin, K ;
Feltwell, T ;
Gentles, S ;
Hamlin, N ;
Holroyd, S ;
Hornby, T ;
Jagels, K ;
Krogh, A ;
McLean, J ;
Moule, S ;
Murphy, L ;
Oliver, K ;
Osborne, J ;
Quail, MA ;
Rajandream, MA ;
Rogers, J ;
Rutter, S ;
Seeger, K ;
Skelton, J ;
Squares, R ;
Squares, S ;
Sulston, JE ;
Taylor, K ;
Whitehead, S ;
Barrell, BG .
NATURE, 1998, 393 (6685) :537-+
[6]   PURIFICATION AND PROPERTIES OF PEROXIDASE IN MYCOBACTERIUM-TUBERCULOSIS H37RV AND ITS POSSIBLE ROLE IN MECHANISM OF ACTION OF ISONICOTINIC-ACID HYDRAZIDE [J].
DEVI, BG ;
SHAILA, MS ;
RAMAKRISHNAN, T ;
GOPINATHAN, KP .
BIOCHEMICAL JOURNAL, 1975, 149 (01) :187-197
[7]  
Dobner P, 1997, INT J TUBERC LUNG D, V1, P365
[8]   AN OUTBREAK OF MULTIDRUG-RESISTANT TUBERCULOSIS AMONG HOSPITALIZED-PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
EDLIN, BR ;
TOKARS, JI ;
GRIECO, MH ;
CRAWFORD, JT ;
WILLIAMS, J ;
SORDILLO, EM ;
ONG, KR ;
KILBURN, JO ;
DOOLEY, SW ;
CASTRO, KG ;
JARVIS, WR ;
HOLMBERG, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (23) :1514-1521
[9]   Global trends in resistance to antituberculosis drugs [J].
Espinal, MA ;
Laszlo, A ;
Simonsen, L ;
Boulahbal, F ;
Kim, SJ ;
Reniero, A ;
Hoffner, S ;
Rieder, HL ;
Binkin, N ;
Dye, C ;
Williams, R ;
Raviglione, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (17) :1294-1303
[10]   TUBERCULOSIS IN NEW-YORK-CITY - TURNING THE TIDE [J].
FRIEDEN, TR ;
FUJIWARA, PI ;
WASHKO, RM ;
HAMBURG, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (04) :229-233